Atypical femoral fractures: Retrospective radiological study of 319 femoral fractures and presentation of clinical cases

Osteoporosis International

Volumn 25, Issue 3, 2014, Pages 993-997

  Bottai, V ^a   Giannotti, S ^a   Dell'Osso, G ^a   De Paola, G ^a   Menconi, A ^a   Falossi, F ^a   Raffaeta G ^a   Guido, G ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Atypical; Bisphosphonate; Femoral fracture; Osteoporosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

AGED; CASE REPORT; CHEMICALLY INDUCED; FEMALE; FEMORAL FRACTURES; HUMAN; INTRAMEDULLARY NAILING; MALE; MIDDLE AGED; OSTEOPOROSIS; PROCEDURES; RADIOGRAPHY; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; FEMORAL FRACTURES; FRACTURE FIXATION, INTRAMEDULLARY; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; RETROSPECTIVE STUDIES;

EID: 84894545901     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-013-2546-8     Document Type: Article

References (16)

1. Gradi MK, Watson JT, Cannada LK (2012) Treatment of femoral fracture nonumion after long-term bisphosphonate. Orthopedics 35(6):e991-995
2. American College of Rheumatology (2001) Reccomendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 44:1496-1503
3. Cranney A, Tugwell P, Adachi J, Weaver B, Zytaruk N, Papaioannou A et al (2002) Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev 23:517-523
4. Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V et al (2002) Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 23:508-516
5. Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90(3):1294-1301
6. Lenart BA, Lorich DG, Lane JM (2008) Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 358(12):1304-1306, 20
7. Annanuntana A, Unnanuntana A, Saleh A, Mensah KA, Kleimeyer JP, Lane JM (2013) Atypical femoral fractures: what do we know about them? J Bone Joint Surg Am 95:e8 (1-13)
8. Abrahamsen B, Eiken P, Eastell R (2009) Subtrochanteric and diaphyseal femur fractures in patients trested with alendronate: a register-based national cohort study. J Bone Miner Res 24:1095-1102
9. Giusti A, Hamdy NAT, Dekkers OM, Ramautar SR, Dijkstra S, Papapoulos SE (2011) Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features. Bone 48:966-971
10. Girgis CM, Seibelet MJ (2011) Atypical femur fractures: a review of the evidence and its implication to clinical practice. Ther Adv Musculoskelet Dis 3(6):301-314, 011 Dec
11. Compston J (2011) Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw. Osteoporos Int 22:2951-2961. doi: 10.1007/s00198-011- 1804-x
12. Mashiba T et al (2011) Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 28(5):524-531
13. Carvalho NNC, Voss LA et al (2011) Atypical femoral fractures during prolongued use of bisphosphonates: short-term responses to strontium ranelate and teriparatide. J Clin Metab. doi: 10.1210/jc.2011-0593
14. Dell RM, Adams AL, Greene DF, Funahashi TT, Silverman SL, Eisemon EO, Zhou H, Burchette RJ, Ott SM et al (2012) Incidence of atypical nontraumatic diaphyseal fractures of the femur. J Bone Miner Res 27(12):2544-2550
15. Giannotti S, Bottai V, Dell'Osso G, De Paola G, Ghilardi M, Guido G (2013) Pseudoarthrosis in atypical femoral fracture: case report. Osteoporos Int. doi: 10.1007/s00198-013-2397-3
16. Giannotti S, Bottai V, Dell'Osso G, De Paola G, Pini E, Guido G (2012) Atrophic femoral nonunion successfully treated with teriparatide. Eur J Orthop Surg Traumatol. doi: 10.1007/s00590-012-1143-4